ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RGT Argent Biopharma Limited

6.00
0.00 (0.00%)
20 Mar 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Argent Biopharma Limited LSE:RGT London Ordinary Share AU0000326647 ORD NPV (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6.00 5.00 7.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Issue of Equity

23/12/2003 7:00am

UK Regulatory


RNS Number:5776T
ReGen Therapeutics PLC
23 December 2003

ReGen Therapeutics Plc

23rd December 2003

ReGen Therapeutics Plc Placing raises #93,400

ReGen Therapeutics Plc ("ReGen" or "the Company") announces that it has today
placed with new and existing shareholders 4.67 million new ordinary shares ("New
Shares") at 2p per share to raise #93,400 before expenses ("Placing").

Application has been made for the New Shares to be admitted to the Alternative
Investment Market of the London Stock Exchange Plc and dealings are expected to
commence at 8am on 23 December 2003.

Executive Chairman Percy Lomax commented "This small Placing has been done by
the Company to allocate shares to a few private investors who had previously
expressed an interest in investing in the Company."

For further information please contact:

Andrew Marshall
Marshall Robinson Roe
Tel No 020 7960 6007


                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
IOEFESFWESDSESE

1 Year Argent Biopharma Chart

1 Year Argent Biopharma Chart

1 Month Argent Biopharma Chart

1 Month Argent Biopharma Chart